SWM
BIO icon

Sanctuary Wealth Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

Sanctuary Wealth Management’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-3
Closed -$1.04K – 265
2024
Q1 		$1.04K Hold
3
– – ﹤0.01% 233
2023
Q4 		$969 Hold
3
– – ﹤0.01% 244
2023
Q3 		$1.07K Hold
3
– – ﹤0.01% 230
2023
Q2 		$1.14K Buy
+3
New +$1.22K ﹤0.01% 238
2022
Q4 		$1.26K Buy
+3
New +$1.21K ﹤0.01% 214

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.9B AUM 3.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Sanctuary Wealth Management's BIO Position: Q2 2024 in Review

Sanctuary Wealth Management sold out of Bio-Rad Laboratories Class A (BIO) in Q2 2024, closing a stake of 3 shares — an estimated $1.04K sold.

Sanctuary Wealth Management first reported a position in BIO in Q4 2022 and held it in 5 quarters. The position peaked at $1.26K in Q4 2022. 439 funds tracked by Wall St. Rank hold BIO as of Q2 2024.

  • Sanctuary Wealth Management reported no remaining Bio-Rad Laboratories Class A position as of Q2 2024 after selling out during the quarter.
  • Sanctuary Wealth Management sold 3 Bio-Rad Laboratories Class A shares in Q2 2024, an estimated $1.04K.
  • Sanctuary Wealth Management first reported a position in Bio-Rad Laboratories Class A in Q4 2022 and held it in 5 quarters.
  • Sanctuary Wealth Management's Bio-Rad Laboratories Class A position peaked at $1.26K in Q4 2022.
  • 439 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2024.

Based on Sanctuary Wealth Management's 13F filing for Q2 2024, filed 8 Aug 2024.